Clinical Trial

Study of Patient With Frequent COPD Exacerbations

Study acronym: PRIORITY-COPD
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This Study is a multicenter, non-interventional, observational, ambispective (retrospective-prospective) study to evaluate clinical and demographic characteristics, approaches to therapy in outpatients with COPD and frequent exacerbations in the Russian Federation. Planned number of Study site is 35 outpatient centers with experience of treatment of COPD with frequency exacerbations in about 30 regions in Russia.
Protocol Amendment History 2 changes
notable Enrollment increased: 1708 -> 2038 participants 2026-07-10
notable Enrollment increased: 1519 -> 1708 participants 2026-06-03
Trial Details
NCT Number NCT07221981
Lead Sponsor AstraZeneca
Conditions Chronic Obstructive Pulmonary Disease (COPD)
Enrollment 2,038 participants
Start Date 2024-12-16
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-09